The FDA and ABCs: The Unintended Consequences of Antidepressant Warnings on Human Capital

Susan Busch, Ezra Golberstein, Ellen Meara

NBER Working Paper No. 17426
Issued in September 2011
NBER Program(s):   CH   HC   HE

Using annual cross-sectional data on over 100,000 adolescents aged 12-17, we studied academic and behavioral outcomes among those who were and were not likely affected by FDA warnings regarding the safety of antidepressants. Just before the FDA warnings, adolescents with probable depression had grade point averages 0.14 points higher than adolescents with depression just after the warnings. The FDA warnings also coincided with increased delinquency, use of tobacco and illicit drugs. Together, our results stress the importance of mental health and its treatment as an input into cognitive and non-cognitive aspects of human capital.

(2916 K)

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

This paper is available as PDF (2916 K) or via email.

Acknowledgments

Machine-readable bibliographic record - MARC, RIS, BibTeX